Amalgamated Bank lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 4.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 39,633 shares of the company’s stock after selling 1,697 shares during the quarter. Amalgamated Bank’s holdings in HCA Healthcare were worth $12,733,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the business. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the period. Finally, LifeSteps Financial Inc. purchased a new position in shares of HCA Healthcare during the first quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors.
Insider Buying and Selling at HCA Healthcare
In related news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,202 shares of company stock valued at $6,407,273. Corporate insiders own 1.60% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Report on HCA Healthcare
HCA Healthcare Stock Performance
Shares of NYSE HCA opened at $399.89 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50 day simple moving average of $367.24 and a two-hundred day simple moving average of $339.56. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $404.90. The stock has a market cap of $104.74 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 1.46 and a beta of 1.67.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the business posted $4.29 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- How to Invest in Small Cap Stocks
- How Much Can You Make in Stocks in One Month?
- Earnings Per Share Calculator: How to Calculate EPS
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Buy Cheap Stocks Step by Step
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.